These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32215885)

  • 1. MicroRNAs: Potential Targets in Diabetic Retinopathy.
    Li X; Yu ZW; Wang Y; Fu YH; Gao XY
    Horm Metab Res; 2020 Mar; 52(3):142-148. PubMed ID: 32215885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between miRNAs expression and signaling pathways of oxidative stress in diabetic retinopathy.
    Satari M; Aghadavod E; Mobini M; Asemi Z
    J Cell Physiol; 2019 Jun; 234(6):8522-8532. PubMed ID: 30478922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy.
    Gong Q; Su G
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29074557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between microRNAs expression and signaling pathways of inflammatory markers in diabetic retinopathy.
    Shafabakhsh R; Aghadavod E; Mobini M; Heidari-Soureshjani R; Asemi Z
    J Cell Physiol; 2019 Jun; 234(6):7781-7787. PubMed ID: 30478931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of noncoding RNAs in diabetic retinopathy: Mechanisms and therapeutic implications.
    Xiao J; Xu Z
    Life Sci; 2024 Nov; 357():123092. PubMed ID: 39368772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive competitive endogenous RNA network pinpoints key molecules in diabetic retinopathy.
    Wu Y; Jia K; Wu H; Sang A; Wang L; Shi L; Jiang K; Dong J
    Mol Med Rep; 2019 Feb; 19(2):851-860. PubMed ID: 30535492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNAs in the modulation of diabetic retinopathy.
    Mastropasqua R; Toto L; Cipollone F; Santovito D; Carpineto P; Mastropasqua L
    Prog Retin Eye Res; 2014 Nov; 43():92-107. PubMed ID: 25128741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of microRNAs in activating neovascularization pathways in diabetic retinopathy.
    Satari M; Aghadavod E; Mirhosseini N; Asemi Z
    J Cell Biochem; 2019 Jun; 120(6):9514-9521. PubMed ID: 30556195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research progress on exosomes/microRNAs in the treatment of diabetic retinopathy.
    Niu SR; Hu JM; Lin S; Hong Y
    Front Endocrinol (Lausanne); 2022; 13():935244. PubMed ID: 36017322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Correlation Between MicroRNAs and Diabetic Retinopathy.
    Zhao X; Ling F; Zhang GW; Yu N; Yang J; Xin XY
    Front Immunol; 2022; 13():941982. PubMed ID: 35958584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic and therapeutic perspectives of non-coding RNA-modulated apoptotic signaling in diabetic retinopathy.
    Wu Q; Liu C; Shu X; Duan L
    Cell Biol Toxicol; 2024 Jul; 40(1):53. PubMed ID: 38970639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA Expression Profiling Based on Microarray Approach in Human Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
    Zhou H; Peng C; Huang DS; Liu L; Guan P
    DNA Cell Biol; 2020 Mar; 39(3):441-450. PubMed ID: 32101049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological roles of lncRNAs in diabetic retinopathy with a focus on oxidative stress and inflammation.
    Chen C; Ding P; Yan W; Wang Z; Lan Y; Yan X; Li T; Han J
    Biochem Pharmacol; 2023 Aug; 214():115643. PubMed ID: 37315816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy.
    Chang X; Zhu G; Cai Z; Wang Y; Lian R; Tang X; Ma C; Fu S
    Front Endocrinol (Lausanne); 2021; 12():771552. PubMed ID: 34858342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of m6A RNA methylation in diabetic retinopathy.
    Kumari N; Karmakar A; Ahamad Khan MM; Ganesan SK
    Exp Eye Res; 2021 Jul; 208():108616. PubMed ID: 33979630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress.
    Dehdashtian E; Mehrzadi S; Yousefi B; Hosseinzadeh A; Reiter RJ; Safa M; Ghaznavi H; Naseripour M
    Life Sci; 2018 Jan; 193():20-33. PubMed ID: 29203148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentially Expressed MicroRNAs in the Development of Early Diabetic Retinopathy.
    Gong Q; Xie J; Liu Y; Li Y; Su G
    J Diabetes Res; 2017; 2017():4727942. PubMed ID: 28706953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy.
    Ji H; Yi Q; Chen L; Wong L; Liu Y; Xu G; Zhao J; Huang T; Li B; Yang Y; Li W; Han L; Duan S
    Clin Chim Acta; 2020 Feb; 501():147-153. PubMed ID: 31678272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Research Related to MicroRNA for Diabetic Retinopathy.
    Luo Y; Li C
    J Diabetes Res; 2024; 2024():8520489. PubMed ID: 38375094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA and diabetic retinopathy-biomarkers and novel therapeutics.
    Smit-McBride Z; Morse LS
    Ann Transl Med; 2021 Aug; 9(15):1280. PubMed ID: 34532417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.